Dividend Investing Ideas Center
Critical Facts You Need to Know About Preferred Stocks
Have you ever wished for the safety of bonds, but the return potential...
BNY Mellon Research Growth Fund, Inc.
DWOCX (Mutual Fund)
BNY Mellon Research Growth Fund, Inc.
Name
As of 12/11/2024Price
Aum/Mkt Cap
YIELD
Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.
Exp Ratio
Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.
Watchlist
Vitals
YTD Return
34.9%
1 yr return
38.4%
3 Yr Avg Return
8.1%
5 Yr Avg Return
16.8%
Net Assets
$1.59 B
Holdings in Top 10
58.7%
52 WEEK LOW AND HIGH
$16.1
N/A
N/A
Expenses
OPERATING FEES
Expense Ratio 1.93%
SALES FEES
Front Load N/A
Deferred Load 1.00%
TRADING FEES
Turnover 31.62%
Redemption Fee N/A
Min Investment
Standard (Taxable)
$1,000
IRA
$750
Fund Classification
Fund Type
Open End Mutual Fund
Name
As of 12/11/2024Price
Aum/Mkt Cap
YIELD
Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.
Exp Ratio
Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.
Watchlist
DWOCX - Profile
Distributions
- YTD Total Return 34.9%
- 3 Yr Annualized Total Return 8.1%
- 5 Yr Annualized Total Return 16.8%
- Capital Gain Distribution Frequency Semi-Annually
- Net Income Ratio -1.32%
- Dividend Yield 0.0%
- Dividend Distribution Frequency Annual
Fund Details
-
Legal NameBNY Mellon Research Growth Fund, Inc.
-
Fund Family NameDreyfus
-
Inception DateSep 30, 2008
-
Shares OutstandingN/A
-
Share ClassC
-
CurrencyUSD
-
Domiciled CountryUS
-
ManagerMonty Kori
Fund Description
To pursue its goals, the fund normally invests at least 80% of its net assets, plus any borrowings for investment purposes, in common stocks. The fund may invest up to 25% of its assets in foreign securities.
The fund's investments are selected through a collaborative process between the fund's portfolio managers and the global research analysts at Newton Investment Management North America, LLC, the fund's sub-adviser, with each analyst responsible for generating investment ideas across their domain expertise. These analysts utilize a fundamental, bottom-up research process to identify investments for the fund. At the same time, ideas can emanate from the portfolio managers who then leverage the expertise of the domain experts. The fund invests in those companies in which the portfolio managers have identified a strong near-term catalyst for earnings growth or share price appreciation.
The fund typically sells a security when the research analyst responsible for the investment believes there has been a negative change in the fundamental factors surrounding the company, the company has become fully valued, or a more attractive opportunity has been identified.
DWOCX - Performance
Return Ranking - Trailing
| Period | DWOCX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| YTD | 34.9% | -8.5% | 59.0% | 38.64% |
| 1 Yr | 38.4% | -6.7% | 90.0% | 31.91% |
| 3 Yr | 8.1%* | -20.9% | 24.6% | 57.75% |
| 5 Yr | 16.8%* | -12.3% | 31.8% | 45.07% |
| 10 Yr | 13.8%* | -4.1% | 22.6% | 60.81% |
* Annualized
Return Ranking - Calendar
| Period | DWOCX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| 2023 | 34.0% | -74.1% | 72.4% | 44.07% |
| 2022 | -45.3% | -85.9% | 4.7% | 92.31% |
| 2021 | 0.1% | -52.4% | 60.5% | 73.81% |
| 2020 | 31.8% | -34.3% | 145.0% | 31.62% |
| 2019 | 15.2% | -6.9% | 49.4% | 90.21% |
Total Return Ranking - Trailing
| Period | DWOCX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| YTD | 34.9% | -8.5% | 59.0% | 38.64% |
| 1 Yr | 38.4% | -6.7% | 90.0% | 31.91% |
| 3 Yr | 8.1%* | -20.9% | 24.6% | 57.75% |
| 5 Yr | 16.8%* | -12.3% | 31.8% | 45.07% |
| 10 Yr | 13.8%* | -4.1% | 22.6% | 60.81% |
* Annualized
Total Return Ranking - Calendar
| Period | DWOCX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| 2023 | 40.8% | -4.6% | 72.4% | 36.31% |
| 2022 | -34.4% | -61.7% | 5.6% | 77.39% |
| 2021 | 17.9% | -39.8% | 118.1% | 71.09% |
| 2020 | 44.9% | 2.8% | 149.2% | 22.21% |
| 2019 | 28.1% | -5.2% | 49.4% | 87.56% |
NAV & Total Return History
DWOCX - Holdings
Concentration Analysis
| DWOCX | Category Low | Category High | DWOCX % Rank | |
|---|---|---|---|---|
| Net Assets | 1.59 B | 296 K | 287 B | 48.14% |
| Number of Holdings | 50 | 2 | 3061 | 65.34% |
| Net Assets in Top 10 | 946 M | 126 K | 150 B | 48.09% |
| Weighting of Top 10 | 58.65% | 0.7% | 205.0% | 27.39% |
Top 10 Holdings
- NVIDIA CORP 13.27%
- APPLE INC 9.17%
- MICROSOFT CORP 8.84%
- AMAZON.COM INC 8.68%
- ALPHABET INC 8.09%
- TRANE TECHNOLOGIES PLC 2.33%
- COSTAR GROUP INC 2.25%
- INTUITIVE SURGICAL INC 2.15%
- SHOPIFY INC 2.06%
- AMETEK INC 1.82%
Asset Allocation
| Weighting | Return Low | Return High | DWOCX % Rank | |
|---|---|---|---|---|
| Stocks | 98.56% | 0.00% | 123.52% | 60.25% |
| Cash | 1.48% | 0.00% | 173.52% | 36.21% |
| Preferred Stocks | 0.00% | 0.00% | 8.45% | 75.23% |
| Other | 0.00% | -36.56% | 42.58% | 77.77% |
| Convertible Bonds | 0.00% | 0.00% | 1.94% | 72.27% |
| Bonds | 0.00% | 0.00% | 102.71% | 72.41% |
Stock Sector Breakdown
| Weighting | Return Low | Return High | DWOCX % Rank | |
|---|---|---|---|---|
| Technology | 41.41% | 0.00% | 65.70% | 24.45% |
| Healthcare | 15.10% | 0.00% | 39.76% | 26.09% |
| Consumer Cyclical | 13.89% | 0.00% | 62.57% | 63.45% |
| Communication Services | 12.13% | 0.00% | 66.40% | 34.00% |
| Industrials | 8.89% | 0.00% | 30.65% | 17.36% |
| Energy | 2.78% | 0.00% | 41.09% | 22.45% |
| Consumer Defense | 2.47% | 0.00% | 25.50% | 66.64% |
| Basic Materials | 1.68% | 0.00% | 18.91% | 38.55% |
| Financial Services | 1.64% | 0.00% | 43.06% | 95.64% |
| Utilities | 0.00% | 0.00% | 16.07% | 79.55% |
| Real Estate | 0.00% | 0.00% | 16.05% | 89.45% |
Stock Geographic Breakdown
| Weighting | Return Low | Return High | DWOCX % Rank | |
|---|---|---|---|---|
| US | 98.56% | 0.00% | 123.52% | 47.91% |
| Non US | 0.00% | 0.00% | 75.46% | 82.03% |
DWOCX - Expenses
Operational Fees
| DWOCX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Expense Ratio | 1.93% | 0.01% | 28.71% | 8.29% |
| Management Fee | 0.75% | 0.00% | 1.50% | 83.36% |
| 12b-1 Fee | 0.75% | 0.00% | 1.00% | 76.72% |
| Administrative Fee | N/A | 0.01% | 1.02% | N/A |
Sales Fees
| DWOCX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Front Load | N/A | 2.25% | 8.50% | N/A |
| Deferred Load | 1.00% | 1.00% | 5.00% | 74.40% |
Trading Fees
| DWOCX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Max Redemption Fee | N/A | 1.00% | 2.00% | N/A |
Related Fees
Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.
| DWOCX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Turnover | 31.62% | 0.00% | 316.74% | 50.05% |
DWOCX - Distributions
Dividend Yield Analysis
| DWOCX | Category Low | Category High | DWOCX % Rank | |
|---|---|---|---|---|
| Dividend Yield | 0.00% | 0.00% | 27.58% | 84.01% |
Dividend Distribution Analysis
| DWOCX | Category Low | Category High | Category Mod | |
|---|---|---|---|---|
| Dividend Distribution Frequency | Annual | Annually | Annual | Annual |
Net Income Ratio Analysis
| DWOCX | Category Low | Category High | DWOCX % Rank | |
|---|---|---|---|---|
| Net Income Ratio | -1.32% | -6.13% | 3.48% | 94.25% |
Capital Gain Distribution Analysis
| DWOCX | Category Low | Category High | Capital Mode | |
|---|---|---|---|---|
| Capital Gain Distribution Frequency | Semi-Annually | Annually | Annually | Annually |
Distributions History
| Date | Amount | Type |
|---|---|---|
| Dec 06, 2024 | $1.157 | CapitalGainLongTerm |
| Dec 06, 2023 | $0.167 | CapitalGainLongTerm |
| Jun 22, 2023 | $0.440 | CapitalGainLongTerm |
| Dec 06, 2022 | $0.158 | CapitalGainLongTerm |
| Jun 22, 2022 | $1.801 | CapitalGainLongTerm |
| Dec 10, 2021 | $1.820 | CapitalGainLongTerm |
| Jun 23, 2021 | $1.237 | OrdinaryDividend |
| Dec 10, 2020 | $1.174 | OrdinaryDividend |
| Jun 23, 2020 | $0.438 | CapitalGainLongTerm |
| Dec 17, 2019 | $0.012 | CapitalGainShortTerm |
| Dec 17, 2019 | $1.031 | CapitalGainLongTerm |
| Jun 20, 2019 | $0.436 | CapitalGainLongTerm |
| Dec 17, 2018 | $0.022 | CapitalGainShortTerm |
| Dec 17, 2018 | $1.472 | CapitalGainLongTerm |
| Jun 22, 2018 | $0.220 | CapitalGainShortTerm |
| Jun 22, 2018 | $0.736 | CapitalGainLongTerm |
| Dec 19, 2017 | $0.088 | CapitalGainShortTerm |
| Dec 19, 2017 | $0.993 | CapitalGainLongTerm |
| Jun 23, 2017 | $0.358 | CapitalGainLongTerm |
| Dec 19, 2016 | $0.708 | CapitalGainLongTerm |
| Dec 17, 2015 | $0.681 | CapitalGainLongTerm |
| Jun 23, 2015 | $0.215 | CapitalGainLongTerm |
| Dec 18, 2014 | $0.610 | CapitalGainLongTerm |
| Jun 18, 2014 | $0.425 | CapitalGainLongTerm |
| Dec 19, 2013 | $0.053 | CapitalGainLongTerm |
| Jun 27, 2012 | $0.009 | OrdinaryDividend |
| Jun 29, 2011 | $0.034 | OrdinaryDividend |
DWOCX - Fund Manager Analysis
Managers
Monty Kori
Start Date
Tenure
Tenure Rank
Jul 30, 2019
2.84
2.8%
Monty is a member of Newton’s equity research team. In his current role, Monty is a senior research analyst on the global research team. Monty joined Newton in September 2021, following the integration of Mellon Investments Corporation’s equity and multi-asset capabilities into the Newton Investment Management Group. Before joining Newton, Monty was a senior research analyst at Mellon Investments Corporation and The Boston Company Asset Management (both BNY Mellon group companies). Prior to joining BNY Mellon, Monty was a sector portfolio manager at Fidelity Management & Research Company. He also served as a research analyst over his ten-year career at Fidelity. Previously, he was an associate at Stone Point Capital and an investment banking analyst at Morgan Stanley in New York.
Matthew Jenkin
Start Date
Tenure
Tenure Rank
Jul 30, 2019
2.84
2.8%
Matt is a member of Newton’s equity research team. Matt is responsible for covering the healthcare sector, specifically biopharmaceutical and medical-technology companies, and managing portfolios in the Smart Cures Innovation strategy. Matt joined Newton in September 2021, following the integration of Mellon Investments Corporation’s equity and multi-asset capabilities into the Newton Investment Management Group. Before joining Newton, Matt was a senior research analyst at Mellon Investments Corporation and The Boston Company Asset Management (both BNY Mellon group companies). Prior to joining BNY Mellon, Matt served as a portfolio manager and analyst covering the healthcare sector at Balyasny Asset Management. Prior to that, he managed global long/short equity healthcare hedge funds and covered the pharmaceuticals, biotechnology and healthcare services industries at Lehman Brothers/Barclays Capital. Prior to joining the investment industry, Matt was a senior research scientist at SmithKline Beecham.
Karen Miki Behr
Start Date
Tenure
Tenure Rank
Sep 22, 2021
0.69
0.7%
Miki is a member of Newton’s equity opportunities team. In her current role, she is a portfolio manager on the growth funds. Miki joined Newton in September 2021, following the integration of Mellon Investments Corporation’s equity and multi-asset capabilities into the Newton Investment Management Group. Before joining Newton, Miki was a senior research analyst at Mellon Investments Corporation and The Boston Company Asset Management (both BNY Mellon group companies). Previously, she was a research analyst with a focus on healthcare. Over her 14 years at the firm, she covered the consumer staples, consumer discretionary and healthcare sectors across EM, EAFE and the US. Prior to joining BNY Mellon, Miki worked at Leerink Swann & Co., a healthcare investment bank, advising venture capital and private equity firms as well as pharmaceutical, biotech and medical-device companies on strategic growth opportunities.
John Porter
Start Date
Tenure
Tenure Rank
Oct 04, 2021
0.65
0.7%
John is Newton’s chief investment officer and head of equity. John is responsible for overseeing all equity strategies. He is also lead portfolio manager for the US Small, Mid and Large Cap Growth Equity strategies. John joined Newton in September 2021, following the integration of Mellon Investments Corporation’s equity and multi-asset capabilities into the Newton Investment Management Group. Before joining Newton, John was chief investment officer at Mellon Investments Incorporation.
Tenure Analysis
| Category Low | Category High | Category Average | Category Mode |
|---|---|---|---|
| 0.04 | 54.45 | 8.25 | 3.08 |
